Elevated levels of neurofilament light (NfL) in CSF are associated with the severity and progression of AD and can help distinguish AD from other types of dementia, making NfL a strong candidate for assessing the extent of neurodegeneration in AD patients. Here, NEFL is linked to Alzheimer disease.